ACUTAAS logo

Acutaas Chemicals Limited

ACUTAAS·NSE·
3,166.30 +5.70 (+0.18%)
Market Cap25988.35 Cr
PE Ratio72.77
Volume3,10,728
Day High - Low3238.80 - 3162.10
52W High-Low3740.00 - 1302.00
DocStoX Score
6.9/10
Fair
Fair Value
Sign in to see
ROE
24.00%
Strong
P/E
72.77x
Expensive
Debt / Equity
0.02
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day3162
3239
52W1302
3740
DocStoX take

Supported by growth (10.0) and quality (9.0), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.9
/10
Fair
Quality
Excellent
ROE 24.0%
Valuation
Expensive
P/E 72.8×
Growth
Strong
Revenue +31.5% 5Y CAGR
Risk
Low risk
D/E 0.02
Momentum
Strong
76% of 52-week range

At a glance

Market Cap
₹25,988 Cr
52W High / Low
₹3740 / ₹1302
Dividend Yield
0.05%
Promoter Holding
32.66%
EPS (TTM)
₹43.51
Book Value
₹202.00

Key highlights

  • Profit compounding 46% a year
  • Capital works hard — ROCE 32%
  • Revenue compounding 31% a year
  • Valuation is weak (0.0/10)
  • Expensive at 73× earnings
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ACUTAAS CHEMICALS LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.